Repaglinide

3 Drugs classified under this active ingredient

Meglitinide Derivative. Repaglinide 0.5, 1, 2 mg.
TABS: 30, 90, 120 x 0.5 mg, 1 mg, 2 mg.
Start dose: Up to 4 mg dly (max. 16 mg)
with main meal.
Type 2 diabetes.
C/I: Pregn., plan to become pregn., lact.,
und. 12 yrs, type 1 diabetes (insulin
depend.), diabet. ketoacidos.,
hypersens., severe hepat. funct. disord.

Meglitinide Derivative. Repaglinide 0.5, 1, 2 mg.
TABS.: 90. The usual init. dose is 0.5 mg before each main meal. Swallow the tabs. with a glass of water immediat. before or up to 30 min. before each main meal. The dose may be adjust., up to 4 mg, to be taken immediate. before or up to 30 min. before each main meal. The max. recomm. dly. dose is 16 mg. See lit.
Treatment of type II diabetes.
C/I: Hypersens. Pts. with type 1 diabetes. Pts. with diabetic ketoacidosis. Severe hep. dis. Concomt. use with gemfibrozil. Preg. Lact.

Meglitinide Analog. Repaglinide 0.5, 1, 2 mg.
tabs 30/90/120 X 0.5/1/2 mg
The usual init. dose is 0.5 mg before each main meal.
Tabs. to be taken with a glass of water immediat. before or up to 30 min. before each main meal. Dose may be adjust., up to 4 mg, to be taken immediat. before or up to 30 min. before each main meal. Max. recomm. dly. dose is 16 mg. See lit.
For adlts with type 2 diab. mell. whose hyperglyc. can no longer be ctrolled satisfactorily by diet, weight reduct. and exercise. Also in combin. with metformin in adlts with type 2 diab. mell. who are not satisfactorily ctrolled on metformin alone. Tmt to be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.
C/I: Hypersens. Pts. with type 1 diabetes/
Pts. with diabetic ketoacidosis/
Severe hep. dis./Concomt. use with gemfibrozil
Pregn./ Lact.